» Articles » PMID: 39760081

Immunomodulatory Peptides: New Therapeutic Horizons for Emerging and Re-emerging Infectious Diseases

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2025 Jan 6
PMID 39760081
Authors
Affiliations
Soon will be listed here.
Abstract

The emergence and re-emergence of multi-drug-resistant (MDR) infectious diseases have once again posed a significant global health challenge, largely attributed to the development of bacterial resistance to conventional anti-microbial treatments. To mitigate the risk of drug resistance globally, both antibiotics and immunotherapy are essential. Antimicrobial peptides (AMPs), also referred to as host defense peptides (HDPs), present a promising therapeutic alternative for treating drug-resistant infections due to their various mechanisms of action, which encompass antimicrobial and immunomodulatory effects. Many eukaryotic organisms produce HDPs as a defense mechanism, for example Purothionin from plant, Defensins, Cathelicidins, and Histatins from humans and many such peptides are currently the focus of research because of their antibacterial, antiviral and anti-fungicidal properties. This article offers a comprehensive review of the immunomodulatory activities of HDPs derived from eukaryotic organisms including humans, plants, birds, amphibians, reptiles, and marine species along with their mechanisms of action and therapeutic benefits.

References
1.
Feng X, Jin S, Wang M, Pang Q, Liu C, Liu R . The Critical Role of Tryptophan in the Antimicrobial Activity and Cell Toxicity of the Duck Antimicrobial Peptide DCATH. Front Microbiol. 2020; 11:1146. PMC: 7326067. DOI: 10.3389/fmicb.2020.01146. View

2.
Yu J, Mookherjee N, Wee K, Bowdish D, Pistolic J, Li Y . Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J Immunol. 2007; 179(11):7684-91. DOI: 10.4049/jimmunol.179.11.7684. View

3.
Bevins C, Salzman N . Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol. 2011; 9(5):356-68. DOI: 10.1038/nrmicro2546. View

4.
Nijnik A, Madera L, Ma S, Waldbrook M, Elliott M, Easton D . Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J Immunol. 2010; 184(5):2539-50. DOI: 10.4049/jimmunol.0901813. View

5.
Barlow P, Beaumont P, Cosseau C, Mackellar A, Wilkinson T, Hancock R . The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Am J Respir Cell Mol Biol. 2010; 43(6):692-702. PMC: 2993089. DOI: 10.1165/rcmb.2009-0250OC. View